Compare SMID & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SMID | TMCI |
|---|---|---|
| Founded | 1960 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Building Materials | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 211.2M | 120.4M |
| IPO Year | 1996 | 2021 |
| Metric | SMID | TMCI |
|---|---|---|
| Price | $34.58 | $1.48 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $4.77 |
| AVG Volume (30 Days) | 4.0K | ★ 783.3K |
| Earning Date | 01-01-0001 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 866.67 | N/A |
| EPS | ★ 1.96 | N/A |
| Revenue | $78,508,000.00 | ★ $212,690,000.00 |
| Revenue This Year | N/A | $0.87 |
| Revenue Next Year | N/A | $8.78 |
| P/E Ratio | $18.04 | ★ N/A |
| Revenue Growth | ★ 31.77 | 1.59 |
| 52 Week Low | $25.16 | $1.31 |
| 52 Week High | $43.62 | $8.84 |
| Indicator | SMID | TMCI |
|---|---|---|
| Relative Strength Index (RSI) | 45.72 | 33.81 |
| Support Level | $33.59 | N/A |
| Resistance Level | $37.90 | $3.06 |
| Average True Range (ATR) | 1.45 | 0.17 |
| MACD | -0.09 | -0.02 |
| Stochastic Oscillator | 34.24 | 21.35 |
Smith-Midland Corp through its subsidiaries invents, develops, manufactures, markets, sells, and installs precast concrete products for primary use in the construction, highway, utilities, and farming industries. The firm's customers are general contractors and federal, state, and local transportation authorities. Its products include Slenderwall, JJhooks, Softsound, Sierra Wall and Easi set. A substantial portion of the company's business is derived from local, state, and federal building projects. The company generates revenues predominantly from the sale, leasing, licensing, shipping, and installation of precast concrete products for the construction, utility, and farming industries.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.